which has worse side effects semaglutide or tirzepatide vs. Semaglutide: What You Should Know semaglutide vs tirzepatide weight loss
Description
Discontinue use if adverse reaction occurs
Thomas Kruse and Sren stergaard reflect on the development of the GLP-1 analogue, semaglutide, which is reshaping peptide therapeutics in type 2 diabetes, weight management, and beyond.
Consistent use over time is recommended to experience the full benefits.
Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial
